Mrinmayee Koltharkar,Sarthak Rastogi and Zarir Udwadia
P D Hinduja National Hospital & Medical Research Centre, India
Scientific Tracks Abstracts: J Pulm Respir Med
Introduction: Interstitial lung disease (ILD) is a diverse group of over 150 disorders
characterized by varying degrees of fibrosis and inflammation of the lung parenchyma or
interstitium. At present, the available pharmacotherapeutic modalities are ineffective in
stopping the natural course of ILD, have plenty of side effects and remain only as palliative
measures making lung transplantation the sole modality to show benefit in terms of mortality.
The need of pulmonary rehabilitation in ILD has only been recently realized. Much of the work
on pulmonary rehabilitation work has been done on COPD and data has been applied to other
chronic respiratory conditions. While ATS/ERS joint committee in their statement on ILD
subgroup have given weak positive recommendation on pulmonary rehabilitation due to lack
of strong evidence, as more research in this field is desired.
Aim: The aim of this study was to determine whether pulmonary rehabilitation (PR) is
effective in improving the exercise capacity, dyspnoea scores and quality of life of the patients
with interstitial lung disease (ILD).
Methods: We have studied 26 consecutive patients diagnosed with ILD (idiopathic pulmonary
fibrosis or non-specific interstitial pneumonia) who consented to undergo an individualized PR
program including patient education and exercise training for 12 weeks with three sessions/
week. Exercise training included endurance training (cycle ergometer and treadmill walking),
strength training (weight cuffs, dumbbell), breathing and flexibility exercise (stretching) under
a trained cardiopulmonary physiotherapist. Exercise capacity was assessed by six minute walk
test (6MWT), dyspnoea score by Borgā??s scale rating resting and post 6MWT and quality of life
by SGRQ. Assessment was done in pre- and post-program.
Results: Out of 26 patients, 24 were able to complete the prescribed 12 weeks program. Out of
26 patients, 10 patients had diagnosis of NSIP and rests were IPF. There were 10 males (38.5%)
in the study. Mean baseline 6 MWD was 340 meters (+/- 47.21 SD) with mean post 12 week
6 MWD of 387 meters (+/-63.57). Mean improvement was 47 meters, 6 MWD is significantly
increased (p<0.0001). Mean value of the baseline post 6 MWT Borgā??s scale rating was 2.57
(+/-1.094 SD) with median value of three and range from 1-4. Mean value of the post 12 week
post 6 MWT Borgā??s scale was 1.82 (+/-0.983 SD) with median value of two, range of 1-2,
was significantly reduced (p=0.0056). Mean baseline SGRQ scores were 50.28 (+/-12.42 SD)
with mean post 12 week SGRQ scores 36.90 (+/-10.84) was significantly reduced (p=0.0013).
Conclusion: Pulmonary rehabilitation significantly improved the exercise capacity, dyspnoea
perception and quality of life in the patients with ILD and should be considered as a standard
of care for patients with ILD.
Mrinmayee Koltharkar has 11 years of extensive experience in the field of Physiotherapy. She is a merit holder in Masters of Cardio-Pulmonary Physiotherapy from KEM Hospital. After completion of Master’s Degree in 2010, she worked at Dr. Balabhai Nanavati Hospital under guidance of Dr. Ali Irani, where she dedicatedly handled ICU patients, undertook the role of a guide for post graduate students and, provided her expertise in various case presentations. Due to her exemplary knowledge, she was invited to present Telemedicine CMEs for African countries. In 2011, she joined P D Hinduja National Hospital & MRC as a Research & Pulmonary Physiotherapist. She is a Research Assistant to India’s best Chest Physicians Dr. Zarir Udwadia & Dr. Ashok Mahashur. She conducted Pulmonary Rehabilitation research for ILD patients under guidance of Dr. Udwadia and co-authored the findings in American Thoracic Society. The second research, Pulmonary Rehabilitation in COPD patients with Dr. Mahashur is now in the process of presentation. In 2012, she was Pulmonary Rehabilitation Physiotherapist for first lung transplant in Mumbai. She is a noteworthy speaker in various national & international workshops & conferences for Physicians & Physiotherapists.
E-mail: drmrink@yahoo.co.in
Pulmonary & Respiratory Medicine received 1690 citations as per Google Scholar report